MENU
LBRX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
LB Pharmaceuticals (LBRX) Earnings Date & Reports
LB Pharmaceuticals Inc is a late-stage biopharmaceutical company developing novel therapies for the treatment of a wide range of neuropsychiatric disorders including schizophrenia, bipolar depression, adjunctive treatment of depressive disorder and other diseases... Show more
A.I. Advisor
published Earnings
LBRX is expected to report earnings to fall 5.85% to -161 cents per share on November 05
Q3'26
Est.
$-1.61
Q2'26
Missed
by $0.93
Q1'26
Missed
by $0.17
Q4'25
Beat
by $0.13
The last earnings report on August 11 showed earnings per share of -171 cents, missing the estimate of -77 cents. With 56.76K shares outstanding, the current market capitalization sits at 1.27B.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Interesting Articles
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Industry
N/A
Address
One Pennsylvania Plaza
Phone
+1 212 605-0300
Employees
27
Web
https://www.lbpharma.us